Enamine Ltd. offers a wide spectrum of product and services for drug discovery. Presently our stock holds over 38 000 building blocks, 1 500 000 compounds for high-throughput screening, and over 100 000 compounds for fragment-based lead design. We also offer ready-to-screen pre-plated sets and targeted compound libraries. Our systematically validated chemistry approach has generated ca. 3 800 000 tangible building blocks over 15 000 000 screening compounds that can be made available tomorrow with high success rate. The most up-to-date databases of the offered structures can be downloaded or searched on-line at enamine.net.